Upgrade to SI Premium - Free Trial

Recursion Pharmaceuticals (RXRX)

2.98 -0.10 (3.25%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 21, 2026 4:12 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 20, 2026 4:11 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 17, 2026 4:11 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 16, 2026 4:13 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 15, 2026 4:13 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 14, 2026 4:08 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 13, 2026 4:32 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 10, 2026 4:10 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jul 07 Filed by: Borgeson Blake July 9, 2026 6:04 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 9, 2026 4:26 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 8, 2026 4:26 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 7, 2026 1:39 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake July 7, 2026 11:37 AM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 6, 2026 3:29 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jul 01 Filed by: Dar Zavain July 2, 2026 5:16 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jul 01 Filed by: Li Dean Y July 2, 2026 5:16 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 2, 2026 12:54 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 1, 2026 5:19 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Borgeson Blake June 22, 2026 4:33 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: HERSHBERG ROBERT June 22, 2026 4:33 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Michor Franziska June 22, 2026 4:32 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Sun Elaine D June 22, 2026 4:32 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Dar Zavain June 22, 2026 4:32 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Li Dean Y June 22, 2026 4:32 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Bumpus Namandje June 22, 2026 4:32 PM - SEC Filing Form 8-K RECURSION PHARMACEUTICAL For: Jun 17 June 18, 2026 5:04 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher June 18, 2026 4:33 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Bumpus Namandje June 18, 2026 9:45 AM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher June 18, 2026 9:37 AM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 15 Filed by: Taylor Ben R June 17, 2026 5:07 PM - SEC Filing The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It June 16, 2026 8:45 AM - PR NewsWire Form 4 RECURSION PHARMACEUTICAL For: Jun 05 Filed by: Gibson Christopher June 5, 2026 5:03 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 05 Filed by: Khan Najat June 5, 2026 5:03 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Khan Najat June 5, 2026 1:30 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher June 5, 2026 10:19 AM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 02 Filed by: Borgeson Blake June 4, 2026 5:05 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 03 Filed by: Bumpus Namandje June 4, 2026 5:05 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Bumpus Namandje June 3, 2026 10:16 AM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake June 2, 2026 11:05 AM - SEC Filing Recursion to Participate in Upcoming Investor Conferences June 2, 2026 8:00 AM - StreetInsider Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules May 29, 2026 4:30 PM - StreetInsider Form 4 RECURSION PHARMACEUTICAL For: May 22 Filed by: Gibson Christopher May 27, 2026 4:15 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher May 22, 2026 10:14 AM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: May 15 Filed by: Khan Najat May 19, 2026 5:55 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: May 15 Filed by: Hallett David May 19, 2026 5:55 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: May 15 Filed by: Gibson Christopher May 19, 2026 5:55 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: May 15 Filed by: Taylor Ben R May 19, 2026 5:55 PM - SEC Filing Altitude Lab Portfolio Companies Surpass $205 Million in Funding, Marking a New Era for Early-Stage Biotechs in Salt Lake City May 19, 2026 12:07 PM - Globe NewsWire Recursion Pharmaceuticals (RXRX) PT Raised to $5.50 at Morgan Stanley May 14, 2026 8:53 AM - StreetInsider Form SCHEDULE 13G RECURSION PHARMACEUTICAL Filed by: STATE STREET CORP May 12, 2026 11:53 AM - SEC Filing The Future of Intoxication Detection May Be in Your Voice May 11, 2026 8:30 AM - Globe NewsWire Form 4 RECURSION PHARMACEUTICAL For: May 07 Filed by: Gibson Christopher May 8, 2026 4:59 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: May 05 Filed by: Borgeson Blake May 7, 2026 4:45 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher May 7, 2026 11:14 AM - SEC Filing Recursion Pharmaceuticals, Inc. (RXRX) Tops Q1 EPS by 4c, offers outlook May 6, 2026 6:34 AM - StreetInsider Form 10-Q RECURSION PHARMACEUTICAL For: Mar 31 May 6, 2026 6:33 AM - SEC Filing Form 8-K RECURSION PHARMACEUTICAL For: May 06 May 6, 2026 6:32 AM - SEC Filing Recursion Reports First Quarter Financial Results and Provides Business Update May 6, 2026 6:30 AM - Globe NewsWire Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake May 5, 2026 10:22 AM - SEC Filing Form ARS RECURSION PHARMACEUTICAL For: Dec 31 April 30, 2026 4:38 PM - SEC Filing Form DEFA14A RECURSION PHARMACEUTICAL April 30, 2026 4:37 PM - SEC Filing Form DEF 14A RECURSION PHARMACEUTICAL For: Apr 30 April 30, 2026 4:36 PM - SEC Filing Form 8-K RECURSION PHARMACEUTICAL For: Apr 28 April 30, 2026 4:33 PM - SEC Filing Recursion Announces Board Transition April 30, 2026 4:30 PM - StreetInsider Recursion Pharmaceuticals (RXRX) PT Lowered to $10 at JPMorgan April 30, 2026 9:26 AM - StreetInsider Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6 April 29, 2026 7:59 AM - Globe NewsWire Form 4 RECURSION PHARMACEUTICAL For: Apr 22 Filed by: Gibson Christopher April 24, 2026 4:23 PM - SEC Filing Form SCHEDULE 13G/A RECURSION PHARMACEUTICAL Filed by: BlackRock, Inc. April 24, 2026 4:13 PM - SEC Filing Full Article List